Identification of High-Risk Disease and Initial Management of Biochemical Recurrence

Identification of High-Risk Disease and Initial Management of Biochemical Recurrence
Stephen A. Boorjian, MD

CME Available: https://auau.auanet.org/node/37229

ACKNOWLEDGEMENTS
This educational activity is supported by independent educational grants from:
Astellas
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Exact Sciences Corporation
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lantheus Medical Imaging
Pfizer, Inc.
Sanofi Genzyme